Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$25.89 - $29.73 $23,948 - $27,500
-925 Reduced 0.76%
121,090 $3.36 Billion
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $14,528 - $18,870
-556 Reduced 0.45%
122,015 $3.51 Billion
Q3 2023

Nov 01, 2023

SELL
$32.09 - $37.51 $736,401 - $860,779
-22,948 Reduced 15.77%
122,571 $4.07 Billion
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $567,589 - $656,688
15,714 Added 12.11%
145,519 $5.34 Billion
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $297,355 - $387,112
7,549 Added 6.17%
129,805 $5.3 Billion
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $5.1 Million - $6.66 Million
122,256 New
122,256 $6.26 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lgt Financial Advisors LLC Portfolio

Follow Lgt Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Financial Advisors LLC with notifications on news.